Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charla C Engels

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nature Reviews. Clinical Oncology|June 25, 2014
How does genome sequencing impact surgery?Marlies S Reimers, Charla C Engels, Peter J K Kuppen, et al.
BMC Cancer|July 7, 2014
Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort studyMarlies S Reimers, Charla C Engels, Hein Putter, et al.
Molecular Oncology|December 27, 2015
The clinical prognostic value of molecular intrinsic tumor subtypes in older breast cancer patients: A FOCUS study analysisCharla C Engels, Mandy Kiderlen, Esther Bastiaannet, et al.
Molecular Oncology|December 27, 2015
The influence of insulin-like Growth Factor-1-Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: A Dutch TEAM substudy analysisCharla C Engels, Nienke A de Glas, Anita Sajet, et al.
Breast Cancer Research and Treatment|November 8, 2013
Tumor immune subtypes distinguish tumor subclasses with clinical implications in breast cancer patientsEsther M de Kruijf, Charla C Engels, Willemien van de Water, et al.
Breast Cancer Research and Treatment|November 7, 2013
The prognostic value of apoptotic and proliferative markers in breast cancerCharla C Engels, Francesca Ruberta, Esther M de Kruijf, et al.
Breast Cancer Research and Treatment|March 13, 2016
The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysisCharla C Engels, Mandy Kiderlen, Esther Bastiaannet, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2013
Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent mannerBegüm Kocatürk, Yascha W Van den Berg, Chris Tieken, et al.
Breast Cancer Research and Treatment|May 17, 2018
Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancerErik J Blok, Charla C Engels, Geeske Dekker-Ensink, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nature Reviews. Clinical Oncology|June 25, 2014
How does genome sequencing impact surgery?Marlies S Reimers, Charla C Engels, Peter J K Kuppen, et al.
BMC Cancer|July 7, 2014
Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort studyMarlies S Reimers, Charla C Engels, Hein Putter, et al.
Molecular Oncology|December 27, 2015
The clinical prognostic value of molecular intrinsic tumor subtypes in older breast cancer patients: A FOCUS study analysisCharla C Engels, Mandy Kiderlen, Esther Bastiaannet, et al.
Molecular Oncology|December 27, 2015
The influence of insulin-like Growth Factor-1-Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: A Dutch TEAM substudy analysisCharla C Engels, Nienke A de Glas, Anita Sajet, et al.
Breast Cancer Research and Treatment|November 8, 2013
Tumor immune subtypes distinguish tumor subclasses with clinical implications in breast cancer patientsEsther M de Kruijf, Charla C Engels, Willemien van de Water, et al.
Breast Cancer Research and Treatment|November 7, 2013
The prognostic value of apoptotic and proliferative markers in breast cancerCharla C Engels, Francesca Ruberta, Esther M de Kruijf, et al.
Breast Cancer Research and Treatment|March 13, 2016
The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysisCharla C Engels, Mandy Kiderlen, Esther Bastiaannet, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2013
Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent mannerBegüm Kocatürk, Yascha W Van den Berg, Chris Tieken, et al.
Breast Cancer Research and Treatment|May 17, 2018
Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancerErik J Blok, Charla C Engels, Geeske Dekker-Ensink, et al.
Pageof 1